Therapeutic implications of the emerging molecular biology of uveal melanoma.
about
Uveal Melanoma Patient-Derived XenograftsChinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)Adjuvant Therapy of Uveal Melanoma: Current StatusMetastatic uveal melanoma: biology and emerging treatmentsImpact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotypeEffect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells.The genetics of uveal melanoma: current insightsGenome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma.A molecular revolution in uveal melanoma: implications for patient care and targeted therapyThe phosphoinositide 3-kinase α selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells.The genetics of uveal melanoma: an emerging framework for targeted therapyHigh throughput mass spectrometry-based mutation profiling of primary uveal melanoma.Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512.Ocular melanoma: an overview of the current status.Translational models of ocular disease.Molecular bases of cutaneous and uveal melanomas.Differential PKC-dependent and -independent PKD activation by G protein α subunits of the Gq family: selective stimulation of PKD Ser⁷⁴⁸ autophosphorylation by Gαq.Detection of GNAQ mutations and reduction of cell viability in uveal melanoma cells with functionalized gold nanoparticles.Ex vivo enrichment of circulating anti-tumor T cells from both cutaneous and ocular melanoma patients: clinical implications for adoptive cell transfer therapyGenetics of primary intraocular tumorsMolecular pathology of uveal melanomaThe mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma.Systemic treatment of metastatic uveal melanoma: review of literature and future perspectivesPhase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma.Melanoma mutagenesis and aberrant cell signaling.Genetic determinants of uveal melanoma.The biology and clinical development of MEK inhibitors for cancer.Patient-derived xenografts recapitulate molecular features of human uveal melanomas.Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma.Update on Metastatic Uveal Melanoma: Progress and Challenges.Selumetinib for the treatment of metastatic uveal melanoma: past and future perspectives.P2RX7-V3 is a novel oncogene that promotes tumorigenesis in uveal melanoma.Assessing Prognosis in Uveal Melanoma.Rare tumors: an eye on the future.Ocular oncology: advances in retinoblastoma, uveal melanoma and conjunctival melanoma.Dysregulated GPCR Signaling and Therapeutic Options in Uveal Melanoma.Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner.Skin metastases in metastatic uveal melanoma: GNAQ/GNA11 mutational analysis as a valuable tool.Uveal melanoma.
P2860
Q26750371-A01F4325-E93D-419C-86B7-397455D82451Q26770492-8FE3D7E5-1339-4D65-A289-6BF88AE02CD8Q26865325-963D63C1-CCAA-48F4-93BE-9D9476684C06Q27028063-584DA22D-8C3E-4357-A0B7-487CA3CF160AQ27334924-8396AAED-ADFC-4F85-964D-9B33BA6B5B42Q27853021-177D3DC3-AC8F-4ADD-AA0B-8109BD2D3891Q27853217-1F568740-7AA5-4EA6-BBDD-B5B85FEC807AQ28073150-2E78AF14-5075-44CF-A60B-D0F123107E00Q33659480-C127BCD3-23BF-4842-B28C-FAE829AD0E1CQ33717375-3CB13E4F-1EC7-45B7-AE9A-562BC63D3D75Q34096861-4CE9F7C6-07B3-43B6-8B86-66749CE41500Q34249080-23DCCB96-BA1B-478F-827A-422CC432969FQ34414476-0013B6AF-B756-430C-B45B-1A9EAE7E9AD0Q34504963-93ED92C5-FD47-4404-ADC4-5EB82555A053Q34653896-DB4F73BF-22DC-44CD-80EA-BC966874E037Q34764453-79C0CF6B-2228-400B-8755-6441C0011131Q35174214-12FBC3D3-8268-41D4-B126-346DA39E2E9BQ35778013-D93C08BE-CE24-4980-90CC-49BD6408735BQ36100681-B095D35A-FF25-443E-9EFD-AC60DA0F9A6EQ36107158-1D7D2684-5029-4990-AA86-88E3BCA2F17FQ36216850-96720759-862A-4E4E-9BFC-6627534BBFF6Q36615059-4EC059A7-5B9F-4EE2-8BB5-96D750E0BFF5Q37269087-1B58A05D-E99C-474C-9202-43F443051118Q37482566-E09512F3-64CC-4BBE-ADFC-DA2197224181Q37655079-33940F68-6A3C-4941-8332-EA67A5A7FF6FQ38146707-DECA6CF8-9313-431B-8A2A-91A7986C5ADBQ38258203-27CA95AD-1AA1-4948-AC6D-EA5622ECD1B6Q38270129-F41220DB-8B21-4796-9A0B-1BDED5D34EB9Q38317188-57D918D7-1521-47D0-9DD5-CF32AB5B94AFQ38718726-902A6ADE-7BC7-4878-8094-B7ED3EF297F6Q38783505-93467CEF-AC9D-481E-B5FB-27B15CF1F19EQ38798084-1BD5F218-417E-4025-B759-73CFF9492809Q38836825-0FCC36D3-47E7-4211-A8B4-286D044E36A0Q38842906-C015F42E-511F-44D6-97F3-60699E725E95Q38966454-A5418ADC-460E-464E-973E-48326FFC1E81Q39030720-E6E9B2F1-510C-408D-89D7-B5EBE4842DA2Q39145837-D428FC48-283B-4AD7-9816-B8A3C866A9CBQ39325158-720E016A-218F-42BA-B80A-8F7CB842190DQ39456532-B20D5CE2-CE75-40FA-9AE7-6813B747BC14Q39726923-5DD8C7E5-4422-4625-B24C-9736A6691BA7
P2860
Therapeutic implications of the emerging molecular biology of uveal melanoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Therapeutic implications of the emerging molecular biology of uveal melanoma.
@ast
Therapeutic implications of the emerging molecular biology of uveal melanoma.
@en
Therapeutic implications of the emerging molecular biology of uveal melanoma.
@nl
type
label
Therapeutic implications of the emerging molecular biology of uveal melanoma.
@ast
Therapeutic implications of the emerging molecular biology of uveal melanoma.
@en
Therapeutic implications of the emerging molecular biology of uveal melanoma.
@nl
prefLabel
Therapeutic implications of the emerging molecular biology of uveal melanoma.
@ast
Therapeutic implications of the emerging molecular biology of uveal melanoma.
@en
Therapeutic implications of the emerging molecular biology of uveal melanoma.
@nl
P2093
P1476
Therapeutic implications of the emerging molecular biology of uveal melanoma
@en
P2093
David H Abramson
Gary K Schwartz
Jedd D Wolchok
Mrinali Patel
Paul B Chapman
Richard D Carvajal
P304
P356
10.1158/1078-0432.CCR-10-3169
P407
P577
2011-03-28T00:00:00Z